Improved time-in-range on continuous glucose monitor with Technosphere insulin compared to insulin Aspart in adults with type 1 diabetes: Stat study per protocol analysis

被引：0
|
作者：
Snell-Bergeon, J. [1 ]
Akturk, H. K. [1 ]
Beck, E. A. [1 ]
Klaff, L. J. [2 ]
Bode, B. W. [3 ]
Peters, A. [4 ]
Bailey, T. S. [5 ]
Garg, S. K. [1 ]
机构：
[1] Univ Colorado, AMC, Barbara Davis Ctr Diabet, Aurora, CO USA
[2] Rainier Clin Res Ctr, Renton, WA USA
[3] Atlanta Diabet Associates, Atlanta, GA USA
[4] USC, Westside Ctr Diabet, Beverly Hills, CA USA
[5] AMCR Clin, Escondido, CA USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
677
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [1] Improved Time-in-Range (TIR) on Continuous Glucose Monitor (CGM) with Technosphere Inhaled Insulin (TI) Compared with Insulin Aspart in T1D Patients-STAT Study
    Snell-Bergeon, Janet K.
    Akturk, Halis K.
    Rewers, Amanda
    Bode, Bruce W.
    Klaff, Leslie J.
    Peters, Anne
    Bailey, Timothy S.
    Garg, Satish K.
    DIABETES, 2018, 67
  • [2] Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study
    Akturk, Halis Kaan
    Snell-Bergeon, Janet K.
    Rewers, Amanda
    Klaff, Leslie J.
    Bode, Bruce W.
    Peters, Anne L.
    Bailey, Timothy S.
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (10) : 639 - 647
  • [3] Improved post-prandial blood glucose excursions with Technosphere inhaled insulin compared to aspart in adult patients with type 1 diabetes: STAT study intention to treat analysis
    Akturk, H. K.
    Snell-Bergeon, J. K.
    Beck, E. A.
    Klaff, L. J.
    Bode, B.
    Peters, A.
    Bailey, T. S.
    Garg, S. K.
    DIABETOLOGIA, 2018, 61 : S399 - S400
  • [4] Faster-Acting Insulin Aspart vs. Insulin Aspart for Adults with Type 1 Diabetes Treated with Insulin Pump and Continuous Glucose Monitoring
    Ranjan, Ajenthen G.
    Schmidt, Signe
    Andersen, Hanne-Charlotte
    Norgaard, Kirsten
    DIABETES, 2024, 73
  • [5] EFFICACY AND SAFETY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION OF FASTER ASPART COMPARED WITH INSULIN ASPART IN TYPE 1 DIABETES
    Klonoff, D.
    Evans, M.
    Lane, W.
    Kempe, H. P.
    Renard, E.
    DeVries, H.
    Graungaard, T.
    Hyseni, A.
    Battelino, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A32 - A33
  • [6] Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery
    Dovc, Klemen
    Spanbauer, Charles
    Chiarle, Eleonora
    Bratina, Natasa
    Frohlich-Reiterer, Elke
    Potocnik, Nejka
    Zaharieva, Dessi P.
    Hropot, Tim
    Fritsch, Maria
    Calhoun, Peter
    Battelino, Tadej
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2147 - 2153
  • [7] TECHNOSPHERE INSULIN REDUCED NOCTURNAL HYPOGLYCEMIA COMPARED TO INSULIN ASPART IN ADULT PATIENTS WITH T1D-STAT STUDY
    Snell-Bergeon, J.
    Akturk, H.
    Peters, A.
    Kaiserman, K.
    Garg, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A168 - A169
  • [8] Cost impact analysis of mealtime fast-acting insulin aspart compared with insulin aspart in adults with Type 1 diabetes in the UK
    Pollock, R. F.
    Parekh, W.
    Watcham, S.
    Hallen, N.
    DIABETIC MEDICINE, 2019, 36 : 166 - 166
  • [9] Improved Postprandial Blood Glucose (PPBG) Excursions with Technosphere Inhaled Insulin (TI) Compared with Aspart in T1D Patients-STAT Study
    Akturk, Halis K.
    Snell-Bergeon, Janet K.
    Rewers, Amanda
    Klaff, Leslie J.
    Peters, Anne
    Bode, Bruce W.
    Bailey, Timothy S.
    DIABETES, 2018, 67
  • [10] Better Postprandial Glucose Stability During Continuous Subcutaneous Infusion with Insulin Aspart Compared with Insulin Lispro in Patients with Type 1 Diabetes
    Di Bartolo, Paolo
    Pellicano, Francesca
    Scaramuzza, Antonio
    Sardu, Cipriana
    Casetti, Tino
    Bosi, Emanuele
    Miselli, Valerio
    Brandolini, Sara
    Fabbri, Tiziano
    Meandri, Piero
    Cannata, Francesco
    DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (06) : 495 - 498
12345